Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature

X-linked hyper-IgM (XHIGM) syndrome is caused by mutations of the CD40LG gene, encoding the CD40L protein. The clinical presentation is characterized by early-onset infections, with profound hypogammaglobulinemia and often elevated IgM, susceptibility to opportunistic infections, such as Pneumocysti...

Full description

Bibliographic Details
Main Authors: Boaz Palterer, Lorenzo Salvati, Manuela Capone, Valentina Mecheri, Laura Maggi, Alessio Mazzoni, Lorenzo Cosmi, Nila Volpi, Lucia Tiberi, Aldesia Provenzano, Sabrina Giglio, Paola Parronchi, Giandomenico Maggiore, Oreste Gallo, Alessandro Bartoloni, Francesco Annunziato, Lorenzo Zammarchi, Francesco Liotta
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.840767/full
_version_ 1818263511059398656
author Boaz Palterer
Boaz Palterer
Lorenzo Salvati
Manuela Capone
Valentina Mecheri
Laura Maggi
Alessio Mazzoni
Lorenzo Cosmi
Lorenzo Cosmi
Nila Volpi
Lucia Tiberi
Lucia Tiberi
Aldesia Provenzano
Sabrina Giglio
Paola Parronchi
Paola Parronchi
Giandomenico Maggiore
Oreste Gallo
Alessandro Bartoloni
Francesco Annunziato
Francesco Annunziato
Lorenzo Zammarchi
Lorenzo Zammarchi
Francesco Liotta
Francesco Liotta
author_facet Boaz Palterer
Boaz Palterer
Lorenzo Salvati
Manuela Capone
Valentina Mecheri
Laura Maggi
Alessio Mazzoni
Lorenzo Cosmi
Lorenzo Cosmi
Nila Volpi
Lucia Tiberi
Lucia Tiberi
Aldesia Provenzano
Sabrina Giglio
Paola Parronchi
Paola Parronchi
Giandomenico Maggiore
Oreste Gallo
Alessandro Bartoloni
Francesco Annunziato
Francesco Annunziato
Lorenzo Zammarchi
Lorenzo Zammarchi
Francesco Liotta
Francesco Liotta
author_sort Boaz Palterer
collection DOAJ
description X-linked hyper-IgM (XHIGM) syndrome is caused by mutations of the CD40LG gene, encoding the CD40L protein. The clinical presentation is characterized by early-onset infections, with profound hypogammaglobulinemia and often elevated IgM, susceptibility to opportunistic infections, such as Pneumocystis jirovecii pneumonia, biliary tract disease due to Cryptosporidium parvum, and malignancy. We report a 41-year-old male presenting with recurrent leishmaniasis, hypogammaglobulinemia, and myopathy. Whole-exome sequencing (WES) identified a missense variant in the CD40LG gene (c.107T>A, p.M36K), involving the transmembrane domain of the protein and a missense variant in the carnitine palmitoyl-transferase II (CPT2; c.593C>G; p.S198C) gene, leading to the diagnosis of hypomorphic XHIGM and CPT2 deficiency stress-induced myopathy. A review of all the previously reported cases of XHIGM with variants in the transmembrane domain showcased that these patients could present with atypical clinical features. Variants in the transmembrane domain of CD40LG act as hypomorphic generating a protein with a lower surface expression. Unlike large deletions or extracellular domain variants, they do not abolish the interaction with CD40, therefore preserving some biological activity.
first_indexed 2024-12-12T19:20:10Z
format Article
id doaj.art-2e57030a27d244f1893271041a33dc56
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-12T19:20:10Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-2e57030a27d244f1893271041a33dc562022-12-22T00:14:36ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-04-011310.3389/fimmu.2022.840767840767Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the LiteratureBoaz Palterer0Boaz Palterer1Lorenzo Salvati2Manuela Capone3Valentina Mecheri4Laura Maggi5Alessio Mazzoni6Lorenzo Cosmi7Lorenzo Cosmi8Nila Volpi9Lucia Tiberi10Lucia Tiberi11Aldesia Provenzano12Sabrina Giglio13Paola Parronchi14Paola Parronchi15Giandomenico Maggiore16Oreste Gallo17Alessandro Bartoloni18Francesco Annunziato19Francesco Annunziato20Lorenzo Zammarchi21Lorenzo Zammarchi22Francesco Liotta23Francesco Liotta24Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyFlow Cytometric Diagnostic Centre and Immunotherapy, Careggi University Hospital, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyImmunology and Cell Therapies Unit, Careggi University Hospital, Florence, ItalyUnit of Neurology and Neurophysiology, Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, ItalyDepartment of Biomedical Experimental and Clinical Sciences “Mario Serio”, University of Florence, Florence, ItalyMedical Genetics Unit, Meyer University Hospital, Firenze, ItalyDepartment of Biomedical Experimental and Clinical Sciences “Mario Serio”, University of Florence, Florence, ItalyMedical Genetics Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyImmunology and Cell Therapies Unit, Careggi University Hospital, Florence, ItalyDepartment of Otorhinolaryngology, Careggi University Hospital, Florence, ItalyDepartment of Otorhinolaryngology, Careggi University Hospital, Florence, ItalyInfectious and Tropical Diseases Unit, Careggi University Hospital, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyFlow Cytometric Diagnostic Centre and Immunotherapy, Careggi University Hospital, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyInfectious and Tropical Diseases Unit, Careggi University Hospital, Florence, ItalyDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyImmunology and Cell Therapies Unit, Careggi University Hospital, Florence, ItalyX-linked hyper-IgM (XHIGM) syndrome is caused by mutations of the CD40LG gene, encoding the CD40L protein. The clinical presentation is characterized by early-onset infections, with profound hypogammaglobulinemia and often elevated IgM, susceptibility to opportunistic infections, such as Pneumocystis jirovecii pneumonia, biliary tract disease due to Cryptosporidium parvum, and malignancy. We report a 41-year-old male presenting with recurrent leishmaniasis, hypogammaglobulinemia, and myopathy. Whole-exome sequencing (WES) identified a missense variant in the CD40LG gene (c.107T>A, p.M36K), involving the transmembrane domain of the protein and a missense variant in the carnitine palmitoyl-transferase II (CPT2; c.593C>G; p.S198C) gene, leading to the diagnosis of hypomorphic XHIGM and CPT2 deficiency stress-induced myopathy. A review of all the previously reported cases of XHIGM with variants in the transmembrane domain showcased that these patients could present with atypical clinical features. Variants in the transmembrane domain of CD40LG act as hypomorphic generating a protein with a lower surface expression. Unlike large deletions or extracellular domain variants, they do not abolish the interaction with CD40, therefore preserving some biological activity.https://www.frontiersin.org/articles/10.3389/fimmu.2022.840767/fullCD40LG geneCD40LG mutationLeishmanialeishmaniasisCPT2 deficiencyCPT2 gene
spellingShingle Boaz Palterer
Boaz Palterer
Lorenzo Salvati
Manuela Capone
Valentina Mecheri
Laura Maggi
Alessio Mazzoni
Lorenzo Cosmi
Lorenzo Cosmi
Nila Volpi
Lucia Tiberi
Lucia Tiberi
Aldesia Provenzano
Sabrina Giglio
Paola Parronchi
Paola Parronchi
Giandomenico Maggiore
Oreste Gallo
Alessandro Bartoloni
Francesco Annunziato
Francesco Annunziato
Lorenzo Zammarchi
Lorenzo Zammarchi
Francesco Liotta
Francesco Liotta
Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature
Frontiers in Immunology
CD40LG gene
CD40LG mutation
Leishmania
leishmaniasis
CPT2 deficiency
CPT2 gene
title Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature
title_full Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature
title_fullStr Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature
title_full_unstemmed Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature
title_short Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature
title_sort variants disrupting cd40l transmembrane domain and atypical x linked hyper igm syndrome a case report with leishmaniasis and review of the literature
topic CD40LG gene
CD40LG mutation
Leishmania
leishmaniasis
CPT2 deficiency
CPT2 gene
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.840767/full
work_keys_str_mv AT boazpalterer variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT boazpalterer variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT lorenzosalvati variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT manuelacapone variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT valentinamecheri variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT lauramaggi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT alessiomazzoni variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT lorenzocosmi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT lorenzocosmi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT nilavolpi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT luciatiberi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT luciatiberi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT aldesiaprovenzano variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT sabrinagiglio variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT paolaparronchi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT paolaparronchi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT giandomenicomaggiore variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT orestegallo variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT alessandrobartoloni variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT francescoannunziato variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT francescoannunziato variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT lorenzozammarchi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT lorenzozammarchi variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT francescoliotta variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature
AT francescoliotta variantsdisruptingcd40ltransmembranedomainandatypicalxlinkedhyperigmsyndromeacasereportwithleishmaniasisandreviewoftheliterature